Response to Tolva et al
Genet Med
.
2020 Apr;22(4):813-814.
doi: 10.1038/s41436-019-0717-5.
Epub 2019 Dec 5.
Authors
Julian R Sampson
1
,
Mev Dominguez-Valentin
2
,
Toni T Seppälä
3
4
,
Pål Møller
2
5
6
Affiliations
1
Institute of Medical Genetics, Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, UK. sampson@cf.ac.uk.
2
Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
3
Department of Gastrointestinal Surgery, Helsinki University Central Hospital, Helsinki, Finland.
4
Clinicum, University of Helsinki, Helsinki, Finland.
5
Department of Medical Genetics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
6
Centre for Cancer Cell Reprogamming, University of Oslo, Oslo, Norway.
PMID:
31801985
DOI:
10.1038/s41436-019-0717-5
No abstract available
Publication types
Letter
Comment
MeSH terms
Colorectal Neoplasms, Hereditary Nonpolyposis*
DNA Mismatch Repair
Data Management
Heterozygote
Humans
Prospective Studies